IFNA1 and systemic lupus erythematosus: Certain pathways driving SLE pathogenesis are enhanced in Black versus White populations, with greater frequencies of patients with elevated IFN-α, B cell activation markers (CD86), and double negative 2 (DN2) autoantibody-producing B cells (14–16).